Brown adipose tissue is associated with cardiometabolic health.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
01 2021
Historique:
received: 14 02 2020
accepted: 09 10 2020
pubmed: 6 1 2021
medline: 20 2 2021
entrez: 5 1 2021
Statut: ppublish

Résumé

White fat stores excess energy, whereas brown and beige fat are thermogenic and dissipate energy as heat. Thermogenic adipose tissues markedly improve glucose and lipid homeostasis in mouse models, although the extent to which brown adipose tissue (BAT) influences metabolic and cardiovascular disease in humans is unclear

Identifiants

pubmed: 33398160
doi: 10.1038/s41591-020-1126-7
pii: 10.1038/s41591-020-1126-7
pmc: PMC8461455
mid: NIHMS1737323
doi:

Substances chimiques

Blood Glucose 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

58-65

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States
Organisme : American Diabetes Association (ADA)
ID : 1-17-ACE-17
Pays : International
Organisme : U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (NCATS)
ID : UL1TR001866
Pays : International

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Bartelt, A. et al. Brown adipose tissue activity controls triglyceride clearance. Nat. Med. 17, 200–205 (2011).
pubmed: 21258337 doi: 10.1038/nm.2297
Seale, P. et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J. Clin. Investig. 121, 96–105 (2011).
pubmed: 21123942 doi: 10.1172/JCI44271
Cohade, C., Osman, M., Pannu, H. K. & Wahl, R. L. Uptake in supraclavicular area fat (‘USA-Fat’): description on
pubmed: 12571205
van Marken Lichtenbelt, W. D. et al. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 360, 1500–1508 (2009).
pubmed: 19357405 doi: 10.1056/NEJMoa0808718
Virtanen, K. A. et al. Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 360, 1518–1525 (2009).
pubmed: 19357407 doi: 10.1056/NEJMoa0808949
Cypess, A. M. et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 360, 1509–1517 (2009).
pmcid: 2859951 pubmed: 19357406 doi: 10.1056/NEJMoa0810780
Yoneshiro, T. et al. Brown adipose tissue, whole-body energy expenditure, and thermogenesis in healthy adult men. Obesity (Silver Spring) 19, 13–16 (2011).
doi: 10.1038/oby.2010.105
Orava, J. et al. Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab. 14, 272–279 (2011).
pubmed: 21803297 doi: 10.1016/j.cmet.2011.06.012
Cronin, C. G. et al. Brown fat at PET/CT: correlation with patient characteristics. Radiology 263, 836–842 (2012).
pubmed: 22623697 doi: 10.1148/radiol.12100683
Steinberg, J. D., Vogel, W. & Vegt, E. Factors influencing brown fat activation in FDG PET/CT: a retrospective analysis of 15,000+ cases. Br. J. Radiol. 90, 20170093 (2017).
pmcid: 5594988 pubmed: 28590773 doi: 10.1259/bjr.20170093
Chen, K. Y. et al. Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): recommendations for standardized FDG-PET/CT experiments in humans. Cell Metab. 24, 210–222 (2016).
pmcid: 4981083 pubmed: 27508870 doi: 10.1016/j.cmet.2016.07.014
Becker, A. S., Nagel, H. W., Wolfrum, C. & Burger, I. A. Anatomical grading for metabolic activity of brown adipose tissue. PLoS ONE 11, e0149458 (2016).
pmcid: 4762683 pubmed: 26901352 doi: 10.1371/journal.pone.0149458
Cao, Q. et al. A pilot study of FDG PET/CT detects a link between brown adipose tissue and breast cancer. BMC Cancer 14, 126 (2014).
pmcid: 3937456 pubmed: 24564204 doi: 10.1186/1471-2407-14-126
Balaz, M. et al. Inhibition of mevalonate pathway prevents adipocyte browning in mice and men by affecting protein prenylation. Cell Metab. 29, 901–916 e908 (2019).
pubmed: 30581121 doi: 10.1016/j.cmet.2018.11.017
Gadea, E. et al. Brown adipose tissue activity in relation to weight gain during chemotherapy in breast cancer patients: a pilot study. Nutr. Cancer 66, 1092–1096 (2014).
pubmed: 25157743 doi: 10.1080/01635581.2014.948212
Ginzac, A. et al. A decrease in brown adipose tissue activity is associated with weight gain during chemotherapy in early breast cancer patients. BMC Cancer 20, 96 (2020).
pmcid: 7001369 pubmed: 32019525 doi: 10.1186/s12885-020-6591-3
Brendle, C. et al. Impact of diverse chemotherapeutic agents and external factors on activation of brown adipose tissue in a large patient collective. Sci. Rep. 9, 1901 (2019).
pmcid: 6374459 pubmed: 30760750 doi: 10.1038/s41598-018-37924-6
Hoeke, G. et al. Role of brown fat in lipoprotein metabolism and atherosclerosis. Circ. Res. 118, 173–182 (2016).
pubmed: 26837747 doi: 10.1161/CIRCRESAHA.115.306647
Blondin, D. P. et al. Selective impairment of glucose but not fatty acid or oxidative metabolism in brown adipose tissue of subjects with type 2 diabetes. Diabetes 64, 2388–2397 (2015).
pubmed: 25677914 doi: 10.2337/db14-1651
Dieli-Conwright, C. M. et al. An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy. Cancer 122, 2646–2653 (2016).
pubmed: 27219902 doi: 10.1002/cncr.30104
Ward, Z. J. et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. N. Engl. J. Med. 381, 2440–2450 (2019).
pubmed: 31851800 doi: 10.1056/NEJMsa1909301
Hanssen, M. J. et al. Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus. Nat. Med. 21, 863–865 (2015).
pubmed: 26147760 doi: 10.1038/nm.3891
Chondronikola, M. et al. Brown adipose tissue activation is linked to distinct systemic effects on lipid metabolism in humans. Cell Metab. 23, 1200–1206 (2016).
pmcid: 4967557 pubmed: 27238638 doi: 10.1016/j.cmet.2016.04.029
Yoneshiro, T. et al. Recruited brown adipose tissue as an antiobesity agent in humans. J. Clin. Invest. 123, 3404–3408 (2013).
pmcid: 3726164 pubmed: 23867622 doi: 10.1172/JCI67803
Blondin, D. P. et al. Contributions of white and brown adipose tissues and skeletal muscles to acute cold-induced metabolic responses in healthy men. J. Physiol. 593, 701–714 (2015).
pubmed: 25384777 doi: 10.1113/jphysiol.2014.283598
M, U. D. et al. Human brown adipose tissue [
doi: 10.1007/s00259-016-3364-y
Blondin, D. P. et al. Dietary fatty acid metabolism of brown adipose tissue in cold-acclimated men. Nat. Commun. 8, 14146 (2017).
pmcid: 5290270 pubmed: 28134339 doi: 10.1038/ncomms14146
Liu, X. et al. Brown adipose tissue transplantation improves whole-body energy metabolism. Cell Res. 23, 851–854 (2013).
pmcid: 3674396 pubmed: 23649313 doi: 10.1038/cr.2013.64
Feldmann, H. M., Golozoubova, V., Cannon, B. & Nedergaard, J. UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab. 9, 203–209 (2009).
pubmed: 19187776 doi: 10.1016/j.cmet.2008.12.014
Muzik, O., Mangner, T. J. & Granneman, J. G. Assessment of oxidative metabolism in brown fat using PET imaging. Front. Endocrinol. 3, 15 (2012).
doi: 10.3389/fendo.2012.00015
Blondin, D. P. et al. Inhibition of intracellular triglyceride lipolysis suppresses cold-induced brown adipose tissue metabolism and increases shivering in humans. Cell Metab. 25, 438–447 (2017).
pubmed: 28089568 doi: 10.1016/j.cmet.2016.12.005
Villarroya, F., Cereijo, R., Villarroya, J. & Giralt, M. Brown adipose tissue as a secretory organ. Nat. Rev. Endocrinol. 13, 26–35 (2017).
pubmed: 27616452 doi: 10.1038/nrendo.2016.136
Berbee, J. F. et al. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development. Nat. Commun. 6, 6356 (2015).
pubmed: 25754609 doi: 10.1038/ncomms7356
Hoeke, G. et al. Short-term cooling increases serum triglycerides and small high-density lipoprotein levels in humans. J. Clin. Lipidol. 11, 920–928.e922 (2017).
pubmed: 28625343 doi: 10.1016/j.jacl.2017.04.117
O’Mara, A. E. et al. Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. J. Clin. Invest. 130, 2209–2219 (2020).
pmcid: 7190915 pubmed: 31961826 doi: 10.1172/JCI131126
Raiko, J., Orava, J., Savisto, N. & Virtanen, K. A. High brown fat activity correlates with cardiovascular risk factor levels cross-sectionally and subclinical atherosclerosis at 5-year follow-up. Arterioscler. Thromb. Vasc. Biol. 40, 1289–1295 (2020).
pubmed: 31941384 doi: 10.1161/ATVBAHA.119.313806
Finlin, B. S. et al. The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans. J. Clin. Invest. 130, 2319–2331 (2020).
pmcid: 7190997 pubmed: 31961829 doi: 10.1172/JCI134892
Yarnell, J. W. et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 83, 836–844 (1991).
pubmed: 1999035 doi: 10.1161/01.CIR.83.3.836
Langenberg, C. & Lotta, L. A. Genomic insights into the causes of type 2 diabetes. Lancet 391, 2463–2474 (2018).
pubmed: 29916387 doi: 10.1016/S0140-6736(18)31132-2
von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370, 1453–1457 (2007).
doi: 10.1016/S0140-6736(07)61602-X
Leitner, B. P. et al. Mapping of human brown adipose tissue in lean and obese young men. Proc. Natl Acad. Sci. USA 114, 8649–8654 (2017).
pubmed: 28739898 pmcid: 5559032 doi: 10.1073/pnas.1705287114

Auteurs

Tobias Becher (T)

Laboratory of Molecular Metabolism, The Rockefeller University, New York, NY, USA.
DZHK (German Centre for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Mannheim, Germany.
Division of Cardiology, First Department of Medicine, University Medical Center Mannheim, Mannheim, Germany.

Srikanth Palanisamy (S)

Laboratory of Molecular Metabolism, The Rockefeller University, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Daniel J Kramer (DJ)

Laboratory of Molecular Metabolism, The Rockefeller University, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.
Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY, USA.

Mahmoud Eljalby (M)

Laboratory of Molecular Metabolism, The Rockefeller University, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Sarah J Marx (SJ)

Laboratory of Molecular Metabolism, The Rockefeller University, New York, NY, USA.

Andreas G Wibmer (AG)

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Scott D Butler (SD)

Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.

Caroline S Jiang (CS)

Center for Clinical and Translational Science, The Rockefeller University, New York, NY, USA.

Roger Vaughan (R)

Weill Cornell Medicine, New York, NY, USA.
Center for Clinical and Translational Science, The Rockefeller University, New York, NY, USA.

Heiko Schöder (H)

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Allyn Mark (A)

Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.

Paul Cohen (P)

Laboratory of Molecular Metabolism, The Rockefeller University, New York, NY, USA. pcohen@rockefeller.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH